Proteomic investigation of whole saliva in Wilson's disease

Journal of Proteomics

Volumn 128, Issue , 2015, Pages 154-163

  Cabras, Tiziana ^a   Sanna, Monica ^a   Manconi, Barbara ^a   Fanni, Daniela ^a   Demelia, Luigi ^a   Sorbello, Orazio ^a   Iavarone, Federica ^b   Castagnola, Massimo ^b,c   Faa, Gavino ^a   Messana, Irene ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c CNR   (Italy)

Author keywords

HPLC ESI MS; Human saliva; Oxidative stress; PIgR; Proteomics; S100A8; S100A9; Wilson's disease; Defensins

Indexed keywords

ALPHA DEFENSIN; CALGRANULIN A; CALGRANULIN B; COPPER; CYSTATIN; CYSTEINE; DISULFIDE; HISTATIN; METHIONINE; METHIONINE SULFOXIDE; PROLINE RICH PROTEIN; SALIVA PROTEIN; SECRETORY COMPONENT; STATHERIN; SULFINIC ACID DERIVATIVE; TRYPTOPHAN; BIOLOGICAL MARKER; PROTEOME;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; DISEASE EXACERBATION; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SALIVA; SALIVA ANALYSIS; WILSON DISEASE; CHEMISTRY; METABOLISM;

ADULT; BIOMARKERS; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; PROTEOME; SALIVA;

EID: 84939457819     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2015.07.033     Document Type: Article

References (64)

1. Hellman N.E., Kono S., Mancini G.M., Hoogeboom A.J., De Jong G.J., Gitlin J.D. Mechanisms of copper incorporation into human ceruloplasmin. J. Biol. Chem. 2002, 277:46632-46638.
2. Ala A., Walker A.P., Ashkan K., Dooley J.S., Schilsky M.L. Wilson's disease. Lancet 2007, 369:397-408.
3. Fanni D., Pilloni L., Orrù S., Coni P., Liguori C., Serra S., Lai M.L., Uccheddu A., Contu L., Van Eyken P., Faa G. Expression of ATP7B in normal human liver. Eur. J. Histochem. 2005, 49:371-378.
4. Huster D., Hoppert M., Lutsenko S., Zinke J., Lehmann C., Mössner J., Berr F., Caca K. Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines. Gastroenterology 2003, 124:335-345.
5. Bugbee D., Davies L., Kenney S., Cox D. Dept. Med. Gen., Univ. Alberta, Canada. Wilson disease mutation database (Accesed 2001). http://www.wilsondisease.med.ualberta.ca/database.asp.
6. Wu F., Wang J., Qiao L., Jiang C. Wilson's disease: a comprehensive review of the molecular mechanisms. Int. J. Mol. Sci. 2015, 16:6419-6431.
7. Gialluisi A., Incollu S., Pippucci T., Lepori M.B., Zappu A., Loudianos G., Romeo G. The homozygosity index (HI) approach reveals high allele frequency for Wilson disease in the Sardinian population. Eur. J. Hum. Genet. 2013, 21:1308-1311.
8. Crisponi G., Nurchi V.M., Gerosa C., Fanni D., Nemolato S., Faa G. Copper uptake and trafficking in the brain. Metal Ions in Neurological Systems 2012, 47-63. Springer, Wien. W. Linert, H. Kozlowski (Eds.).
9. Carta M., Mura G., Sorbello O., Farina G., Demelia L. Quality of life and psychiatric symptoms in Wilson's disease: the relevance of bipolar disorders. Clin. Pract. Epidemiol. Ment. Health 2012, 8:102-109.
10. Gitlin J.D. Wilson disease. Gastroenterology 2003, 125:1868-1877.
11. Ferenci P., Caca K., Loudianos G., Mieli-Vergani G., Tanner S., Sternlieb I., Schilsky M., Cox D., Berr F. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003, 23:139-142.
12. Roberts E.A., Schilsky M.L. A practice guideline on Wilson disease. Hepatology 2003, 37:1475-1492.
13. Steindl P., Ferenci P., Dienes H.P., Grimm G., Pabinger I., Madl C., Maier-Dobersberger T., Herneth A., Dragosics B., Meryn S., Knoflach P., Granditsch G., Gangl A. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997, 113:212-218.
14. Ferenci P., Steindl-Munda P., Vogel W., Jessner W., Gschwantler M., Stauber R., Datz C., Hackl F., Wrba F., Bauer P., Lorenz O. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease. Clin. Gastroenterol. Hepatol. 2005, 3:811-818.
15. Sini M., Sorbello O., Sanna F., Battolu F., Civolani A., Fanni D., Faa G., Demelia L. Histologic evolution and long-term outcome of Wilson's disease: results of a single-center experience. Eur. J. Gastroenterol. Hepatol. 2013, 25:111-117.
16. Liggi M., Mais C., Demurtas M., Sorbello O., Demelia E., Civolani A., Demelia L. Uneven distribution of hepatic copper concentration and diagnostic value of double-sample biopsy in Wilson's disease. Scand. J. Gastroenterol. 2013, 48:1452-1458.
17. Lee B.H., Kim J.M., Heo S.H., Mun J.H., Kim J., Kim J.H., Jin H.Y., Kim G.H., Choi J.H., Yoo H.W. Proteomic analysis of the hepatic tissue of Long-Evans Cinnamon (LEC) rats according to the natural course of Wilson disease. Proteomics 2011, 11:3698-3705.
18. Simpson D.M., Beynon R.J., Robertson D.H., Loughran M.J., Haywood S. Copper-associated liver disease: a proteomics study of copper challenge in a sheep model. Proteomics 2004, 4:524-536.
19. Wilmarth P.A., Short K.K., Fiehn O., Lutsenko S., David L.L., Burkhead J.L. A systems approach implicates nuclear receptor targeting in the Atp7b(-/-) mouse model of Wilson's disease. Metallomics 2012, 4:660-668.
20. Roelofsen H., Balgobind R., Vonk R.J. Proteomic analyzes of copper metabolism in an in vitro model of Wilson disease using surface enhanced laser desorption/ionization-time of flight-mass spectrometry. J. Cell. Biochem. 2004, 93:732-740.
21. Park J.Y., Mun J.H., Lee B.H., Heo S.H., Kim G.H., Yoo H.W. Proteomic analysis of sera of asymptomatic, early-stage patients with Wilson's disease. Proteomics Clin. Appl. 2009, 3:1185-1190.
22. Zhang Z., Marshall A.G. An universal algorithm for fast and automated charge state deconvolution of electrospray mass-to-charge ratio spectra. J. Am. Soc. Mass Spectrom. 1998, 9:225-233.
23. Castagnola M., Cabras T., Iavarone F., Vincenzoni F., Vitali A., Pisano E., Nemolato S., Scarano E., Fiorita A., Vento G., Tirone C., Romagnoli C., Cordaro M., Paludetti G., Faa G., Messana I. Top-down platform for deciphering the human salivary proteome. J. Matern. Fetal Neonatal Med. 2012, 25:27-43.
24. Messana I., Cabras T., Pisano E., Sanna M.T., Olianas A., Manconi B., Pellegrini M., Paludetti G., Scarano E., Fiorita A., Agostino S., Contucci A.M., Calò L., Picciotti P.M., Manni A., Bennick A., Vitali A., Fanali C., Inzitari R., Castagnola M. Trafficking and postsecretory events responsible for the formation of secreted human salivary peptides: a proteomics approach. Mol. Cell. Proteomics 2008, 7:911-926.
25. Cabras T., Pisano E., Mastinu A., Denotti G., Pusceddu P.P., Inzitari R., Fanali C., Nemolato S., Castagnola M., Messana I. Alterations of the salivary secretory peptidome profile in children affected by type 1 diabetes. Mol. Cell. Proteomics 2010, 9:2099-2108.
26. Castagnola M., Inzitari R., Fanali C., Iavarone F., Vitali A., Desiderio C., Vento G., Tirone C., Romagnoli C., Cabras T., Manconi B., Sanna M.T., Boi R., Pisano E., Olianas A., Pellegrini M., Nemolato S., Heizmann C.W., Faa G., Messana I. The surprising composition of the salivary proteome of preterm human newborn. Mol. Cell. Proteomics 2011, 10. (M110.003467).
27. Castagnola M., Cabras T., Iavarone F., Fanali C., Messana I. Detection of Ca2+-binding S100 proteins in human saliva by HPLC-ESI-MS. Methods in Molecular Biology 2013, vol. 963:357-371. Springer Protocols, Humana Press, New York. C. Heizmann (Ed.).
28. Ong S.E., Mann M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 2005, 1:252-262.
29. Messana I., Inzitari R., Fanali C., Cabras T., Castagnola M. Facts and artifacts in proteomics of body fluids. What proteomics of saliva is telling us?. J. Sep. Sci. 2008, 31:1948-1963.
30. Cabras T., Pisano E., Boi R., Olianas A., Manconi B., Inzitari R., Fanali C., Giardina B., Castagnola M., Messana I. Age-dependent modifications of the human salivary secretory protein complex. J. Proteome Res. 2009, 8:4126-4134.
31. Cabras T., Melis M., Castagnola M., Padiglia A., Tepper B.J., Messana I., Tomassini Barbarossa I. Responsiveness to 6-n-propylthiouracil (PROP) is associated with salivary levels of two specific basic proline-rich proteins in humans. PLoS One 2012, 7:e30962.
32. Shetty V., Spellman D.S., Neubert T.A. Characterization by tandem mass spectrometry of stable cysteine sulfenic acid in a cysteine switch peptide of matrix metalloproteinases. J. Am. Soc. Mass Spectrom. 2007, 18:1544-1551.
33. Wang Y., Vivekananda S., Men L., Zhang Q. Fragmentation of protonated ions of peptides containing cysteine, cysteine sulfinic acid, and cysteine sulfonic acid. J. Am. Soc. Mass Spectrom. 2004, 15:697-702.
34. Edgeworth J., Gorman M., Bennett R., Freemont P., Hogg N. Identification of p8, 14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J. Biol. Chem. 1991, 266:7706-7713.
35. Goyette J., Geczy C.L. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids 2011, 41:821-842.
36. Carlsson H., Yhr M., Petersson S., Collins N., Polyak K., Enerbäck C. Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants. Cancer Biol. Ther. 2005, 4:998-1005.
37. Moles A., Murphy L., Wilson C.L., Chakraborty J.B., Fox C., Park E.J., Mann J., Oakley F., Howarth R., Brain J., Masson S., Karin M., Seki E., Mann D.A. A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse. J. Hepatol. 2014, 60:782-791.
38. Wiechert L., Németh J., Pusterla T., Bauer C., De Ponti A., Manthey S., Marhenke S., Vogel A., Klingmüller U., Hess J., Angel P. Hepatocyte-specific S100A8 and S100A9 transgene expression in mice causes Cxcl1 induction and systemic neutrophil enrichment. Cell Commun. Signal. 2012, 10:40.
39. Schenten V., Melchior C., Steinckwich N., Tschirhart E.J., Bréchard S. Sphingosine kinases regulate NOX2 activity via p38 MAPK-dependent translocation of S100A8/A9. J. Leukoc. Biol. 2011, 89:587-596.
40. Doussiere J., Bouzidi F., Vignais P.V. The S100A8/A9 protein as a partner for the cytosolic factors of NADPH oxidase activation in neutrophils. Eur. J. Biochem. 2002, 269:3246-3255.
41. Hussain S.P., Raja K., Amstad P.A., Sawyer M., Trudel L.J., Wogan G.N., Hofseth L.J., Shields P.G., Billiar T.R., Trautwein C., Hohler T., Galle P.R., Phillips D.H., Markin R., Marrogi A.J., Harris C.C. Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: oxyradical overload diseases. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12770-12775.
42. Ogihara H., Ogihara T., Miki M., Yasuda H., Mino M. Plasma copper and antioxidant status in Wilson's disease. Pediatr. Res. 1995, 37:219-226.
43. Gomes L.H., Raftery M.J., Yan W.X., Goyette J.D., Thomas P.S., Geczy C.L. S100A8 and S100A9-oxidant scavengers in inflammation. Free Radic. Biol. Med. 2013, 58:70-86.
44. Biteau B., Labarre J., Toledano M.B. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 2003, 425:980-984.
45. Budanov A.V., Sablina A.A., Feinstein E., Koonin E.V., Chumakov P.M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 2004, 304:596-600.
46. Martínez-Ruiz A., Cadenas S., Lamas S. Nitric oxide signaling: classical, less classical and nonclassical mechanisms. Free Radic. Biol. Med. 2011, 51:17-29.
47. Hill B.G., Bhatnagar A. Protein S-glutathiolation: redox-sensitive regulation of protein function. J. Mol. Cell. Cardiol. 2012, 52:559-567.
48. Lindahl M., Mata-Cabana A., Kieselbach T. The disulfide proteome and other reactive cysteine proteomes: analysis and functional significance. Antioxid. Redox Signal. 2011, 14:2581-2642.
49. Sroussi H.Y., Lu Y., Villines D., Sun Y. The down regulation of neutrophil oxidative metabolism by S100A8 and S100A9: implication of the protease-activated receptor-2. Mol. Immunol. 2012, 50:42-48.
50. Lim S.Y., Raftery M.J., Goyette J., Geczy C.L. S-glutathionylation regulates inflammatory activities of S100A9. J. Biol. Chem. 2010, 285:14377-14388.
51. Kumar R.K., Yang Z., Bilson S., Thliveris S., Cooke B.E., Geczy C.L. Dimeric S100A8 in human neutrophils is diminished after phagocytosis. J. Leukoc. Biol. 2001, 70:59-64.
52. Harrison C.A., Raftery M.J., Walsh J., Alewood P., Iismaa S.E., Thliveris S., Geczy C.L. Oxidation regulates the inflammatory properties of the murine S100 protein S100A8. J. Biol. Chem. 1999, 274:8561-8569.
53. Lim S.Y., Raftery M.J., Goyette J., Hsu K., Geczy C.L. Oxidative modifications of S100 proteins: functional regulation by redox. J. Leukoc. Biol. 2009, 86:577-587.
54. Asano M., Komiyama K. Polymeric immunoglobulin receptor. J. Oral Sci. 2011, 53:147-156.
55. Kaetzel C.S. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol. Rev. 2005, 206:83-99.
56. Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T., Loo J.A. Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J. Proteome Res. 2006, 5:1493-1503.
57. Ai J., Tang Q., Wu Y., Xu Y., Feng T., Zhou R., Chen Y., Gao X., Zhu Q., Yue X., Pan Q., Xu S., Li J., Huang M., Daugherty-Holtrop J., He Y., Xu H.E., Fan J., Ding J., Geng M. The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma. J. Natl. Cancer Inst. 2011, 103:1696-1712.
58. Fu J.L., Wang Y.R., Li G.Z., Zhou Y., Liu P. Change in expression of the intestinal polymeric immunoglobulin receptor in acute liver necrosis. J. Gastroenterol. Hepatol. Res. 2012, 1:69-73.
59. Valore E.V., Ganz T. Posttranslational processing of defensins in immature human myeloid cells. Blood 1992, 79:1538-1544.
60. Chaly Y.V., Paleolog E.M., Kolesnikova T.S., Tikhonov I.I., Petratchenko E.V., Voitenok N.N. Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. Eur. Cytokine Netw. 2000, 11:257-266.
61. Lehrer R.I., Lu W. α-Defensins in human innate immunity. Immunol. Rev. 2012, 245:84-112.
62. Singh A., Bateman A., Zhu Q.Z., Shimasaki S., Esch F., Solomon S. Structure of a novel human granulocyte peptide with anti-ACTH activity. Biochem. Biophys. Res. Commun. 1988, 155:524-529.
63. Gedamu L., Foster R., Jahroudi N., Samson S.L., Shworak N.W., Zafarullah M. Regulation of human and rainbow trout metallothionein genes. Metallothionein II: Biological Roles and Medical Implications 1993, 365-382. Berkhäuser Verlag, Basel. K.T. Suzuki, N. Imura, M. Kimura (Eds.).
64. Miles A.T., Hawksworth G.M., Beattie J.H., Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit. Rev. Biochem. Mol. Biol. 2000, 35:35-70.